Tricuspid Regurgitation clinical trials at UC Davis
1 research study open to eligible people
open to eligible people ages 18 years and up
The primary objective of this trial is to demonstrate the safety and effectiveness of the TriClip device in improving clinical outcomes in symptomatic patients with severe tricuspid regurgitation (TR), who are at intermediate or greater estimated risk for mortality or morbidity with tricuspid valve surgery. This randomized controlled trial will compare the investigational device (TriClip device) to Control (Medical Therapy).
Sacramento, California and other locations
Our lead scientists for Tricuspid Regurgitation research studies include Gagan Singh.